Rapid Biofluid Analyzer
The RBA is an in-vitro prescription-use whole blood hemoglobin assay designed to quantify Hgb concentration in whole blood samples within 2 minutes without the use of reagents. Optimized for both operator safety & laser efficacy, our top-down spectrometer model allows the operator to seamlessly load blood samples into the device while minimizing risk of exposure or cross-contamination, and preventing any ambient light from entering the device or corrupting the sample.
The target population includes all adults of age 21 years and older with no bias towards sex, ethnicity, or vulnerable populations within the age range given. Due to its small size and ease of use, the device may occupy a variety of clinical settings, with emergency rooms, point-of-care offices, and doctor’s offices being the current target settings
An issue that requires early detection & monitoring
High hemoglobin levels could signal a rare blood disorder called polycythemia, in which the body makes too many red blood cells and causes it to be thicker than usual. This can lead to clots, heart attacks, and stroke. It is a serious lifelong condition that can be fatal without treatment. Low hemoglobin levels could signal numerous forms of anemia. Early detection of anomalous hemoglobin levels can help reduce the risk of more serious or lethal conditions forming